Top

European Journal of Trauma and Emergency Surgery

Published in:

Open Access 27-08-2022 | Original Article

Long-term outcomes after using retrievable vena cava filters in major trauma patients with contraindications to prophylactic anticoagulation

Authors: Kwok M. Ho, Priya Patel, Jenny Chamberlain, Sana Nasim, Frederick B. Rogers

Published in: European Journal of Trauma and Emergency Surgery | Issue 1/2023

Abstract

Purpose

To investigate the long-term outcomes of using vena cava filters to prevent symptomatic pulmonary embolism (PE) in major trauma patients who have contraindications to prophylactic anticoagulation.

Methods

This was an a priori sub-study of a randomized controlled trial (RCT) involving long-term outcome data of 223 patients who were enrolled in Western Australia. State-wide clinical information system, radiology database and death registry were used to assess long-term outcomes, including incidences of venous thromboembolism, venous injury and mortality beyond day-90 follow-up.

Results

The median follow-up time of 198 patients (89%) who survived beyond 90 days was 65 months (interquartile range 59–73). Ten patients (5.1%) died after day-90 follow-up; and four patients developed venous thromboembolism, including two with symptomatic PE, all allocated to the control group (0 vs 4%, p = 0.043). Inferior vena cava injuries were not recorded in any patients. The mean total hospitalization cost, including the costs of the filter and its insertion and removal, to prevent one short- or long-term symptomatic PE was A$284,820 (€193,678) when all enrolled patients were considered. The number of patients needed to treat (NNT = 5) and total hospitalization cost to prevent one symptomatic PE (A$1,205 or €820) were, however, substantially lower when the filter was used only for patients who could not be anticoagulated within seven days of injury.

Conclusion

Long-term complications related to retrievable filters were rare, and the cost of using filters to prevent symptomatic PE was acceptable when restricted to those who could not be anticoagulated within seven days of severe injury.

Available only for authorised users

Ball IM, Curtis M, Parry N, Priestap F, Vogt KN. The question of whether vena cava filters have a role in trauma patients remains unanswered. Can J Surg. 2021;64(2):E244–5. https://doi.org/10.1503/cjs.016619.CrossRefPubMedPubMedCentral

Hunter R, Noble S, Lewis S, Bennett P. Long-term psychosocial impact of venous thromboembolism: a qualitative study in the community. BMJ Open. 2019;9(2): e024805. https://doi.org/10.1136/bmjopen-2018-024805.CrossRefPubMedPubMedCentral

Kahn SR, Akaberi A, Granton JT, Anderson DR, Wells PS, Rodger MA, Solymoss S, Kovacs MJ, Rudski L, Shimony A, Dennie C, Rush C, Hernandez P, Aaron SD, Hirsch AM. Quality of life, dyspnea, and functional exercise capacity following a first episode of pulmonary embolism: results of the ELOPE Cohort Study. Am J Med. 2017;130(8):990.e9-990.e21. https://doi.org/10.1016/j.amjmed.2017.03.033.CrossRefPubMed

Ho KM, Rogers FB, Chamberlain J, Nasim S. Incremental cost of venous thromboembolism in trauma patients with contraindications to prophylactic anticoagulation: a prospective economic study. J Thromb Thrombolysis. 2022;54(1):115–22. https://doi.org/10.1007/s11239-021-02618-w.CrossRefPubMed

Ho KM, Rogers FB, Rao S, Chamberlain J, Geelhoed E. Cost-effectiveness of early placement of vena cava filters to prevent symptomatic pulmonary embolism in patients with contraindications to prophylactic anticoagulant. Vasc Med. 2021;26(6):641–7. https://doi.org/10.1177/1358863X211023559.CrossRefPubMed

Ho KM, Tan JA, Burrell M, Rao S, Misur P. Venous thrombotic, thromboembolic, and mechanical complications after retrievable inferior vena cava filters for major trauma. Br J Anaesth. 2015;114(1):63–9. https://doi.org/10.1093/bja/aeu195.CrossRefPubMed

Ayad MT, Gillespie DL. Long-term complications of inferior vena cava filters. J Vasc Surg Venous Lymphat Disord. 2019;7(1):139–44. https://doi.org/10.1016/j.jvsv.2018.01.022.CrossRefPubMed

Ho KM, Rao S, Honeybul S, Zellweger R, Wibrow B, Lipman J, Holley A, Kop A, Geelhoed E, Corcoran T. Detailed assessment of benefits and risks of retrievable inferior vena cava filters on patients with complicated injuries: the da Vinci multicentre randomised controlled trial study protocol. BMJ Open. 2017;7(7): e016747. https://doi.org/10.1136/bmjopen-2017-016747.CrossRefPubMedPubMedCentral

Ho KM, Rao S, Honeybul S, Zellweger R, Wibrow B, Lipman J, Holley A, Kop A, Geelhoed E, Corcoran T, Misur P, Edibam C, Baker RI, Chamberlain J, Forsdyke C, Rogers FB. A multicenter trial of vena cava filters in severely injured patients. N Engl J Med. 2019;381(4):328–37. https://doi.org/10.1056/NEJMoa180651.CrossRefPubMed

10.

Ho KM, Burrell M, Rao S, Baker R. Incidence and risk factors for fatal pulmonary embolism after major trauma: a nested cohort study. Br J Anaesth. 2010;105(5):596–602. https://doi.org/10.1093/bja/aeq254.CrossRefPubMedPubMedCentral

11.

Spangler EL, Dillavou ED, Smith KJ. Cost-effectiveness of guidelines for insertion of inferior vena cava filters in high-risk trauma patients. J Vasc Surg. 2010;52(6):1537–45. https://doi.org/10.1016/j.jvs.2010.06.152.CrossRefPubMed

12.

Phair J, Denesopolis J, Lipsitz EC, Scher L. Inferior vena cava filter malpractice litigation: damned if you do, damned if you don’t. Ann Vasc Surg. 2018;50:15–20. https://doi.org/10.1016/j.avsg.2018.01.093.CrossRefPubMed

13.

Deso SE, Idakoji IA, Kuo WT. Evidence-based evaluation of inferior vena cava filter complications based on filter type. Semin Intervent Radiol. 2016;33(2):93–100. https://doi.org/10.1055/s-0036-1583208.CrossRefPubMedPubMedCentral

14.

Ho KM, Holley A, Lipman J. Vena cava filters in severely-injured patients: one size does not fit all. Anaesth Crit Care Pain Med. 2019;38(4):305–7. https://doi.org/10.1016/j.accpm.2019.07.003.CrossRefPubMed

15.

McKinley WO, Jackson AB, Cardenas DD, DeVivo MJ. Long-term medical complications after traumatic spinal cord injury: a regional model systems analysis. Arch Phys Med Rehabil. 1999;80(11):1402–10. https://doi.org/10.1016/s0003-9993(99)90251-4.CrossRefPubMed

16.

Giorgi Pierfranceschi M, Donadini MP, Dentali F, Ageno W, Marazzi M, Bocchi R, Imberti D. The short- and long-term risk of venous thromboembolism in patients with acute spinal cord injury: a prospective cohort study. Thromb Haemost. 2013;109(1):34–8. https://doi.org/10.1160/TH12-06-0390.CrossRefPubMed

17.

Kaufman JA, Barnes GD, Chaer RA, Cuschieri J, Eberhardt RT, Johnson MS, Kuo WT, Murin S, Patel S, Rajasekhar A, Weinberg I, Gillespie DL. Society of interventional radiology clinical practice guideline for inferior vena cava filters in the treatment of patients with venous thromboembolic disease: developed in collaboration with the American college of cardiology, American college of chest physicians, American college of surgeons committee on trauma, American heart association, society for vascular surgery, and society for vascular medicine. J Vasc Interv Radiol. 2020;31(10):1529–44. https://doi.org/10.1016/j.jvir.2020.06.014.CrossRefPubMed

18.

Brown JD, Raissi D, Han Q, Adams VR, Talbert JC. Vena cava filter retrieval rates and factors associated with retrieval in a large US cohort. J Am Heart Assoc. 2017;6(9): e006708. https://doi.org/10.1161/JAHA.117.006708.CrossRefPubMedPubMedCentral

19.

Ho KM, Chamberlain J, Nasim S, Rogers FB, Kop A. A prospective ex vivo biomechanical analysis of retrievable inferior vena cava filters. J Vasc Surg Venous Lymphat Disord. 2022. https://doi.org/10.1016/j.jvsv.2022.04.007.CrossRefPubMedPubMedCentral

20.

Tobaiqy M, MacLure K, Elkout H, Stewart D. Thrombotic adverse events reported for Moderna, Pfizer and Oxford-Astrazeneca COVID-19 vaccines: comparison of occurrence and clinical outcomes in the eudravigilance database. Vaccines (Basel). 2021;9(11):1326. https://doi.org/10.3390/vaccines9111326.CrossRefPubMed

Title: Long-term outcomes after using retrievable vena cava filters in major trauma patients with contraindications to prophylactic anticoagulation
Authors: Kwok M. Ho
Priya Patel
Jenny Chamberlain
Sana Nasim
Frederick B. Rogers
Publication date: 27-08-2022
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Trauma and Emergency Surgery / Issue 1/2023
Print ISSN: 1863-9933
Electronic ISSN: 1863-9941
DOI: https://doi.org/10.1007/s00068-022-02074-y

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Long-term outcomes after using retrievable vena cava filters in major trauma patients with contraindications to prophylactic anticoagulation

Abstract

Purpose

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2023

Contrast-enhanced computed tomography abdomen versus diagnostic laparoscopy-based management in patients with penetrating abdominal trauma: a randomised controlled trial

Clinical practice selectively follows acute appendicitis guidelines

Race does matter: venous thromboembolism in trauma patients with isolated severe pelvic fractures

The clinical characteristics and management of paediatric pelvic fractures: a changing landscape based on skeletal maturity

Biomechanical comparison of screw vs. cerclage refixation in orthogeriatric lesser trochanteric fractures: a cadaveric study

What are the long-term patient-reported and clinical outcomes after lateral clavicle fractures? A cross-sectional study of 619 patients